Abstract
Although roll-out of HIV pre-exposure prophylaxis (PrEP) has been reported to have changed contexts of HIV risk in areas where it was well-implemented. The rate of its uptake and retention amongst young females has not been described in Gauteng Province. This paper aimed at assessing PrEP uptake and retention among young females in Gauteng Province. Total of young females who tested HIV across five clinics from 01/January/2017 to 31/December/2020 was 19,671 with 17,937 tested HIV negative. Of the HIV tested negative, PrEP was initiated to 1307 (7%). The analysis revealed that 27% of young females returned for their first follow up visit after PrEP initiation, while third month declined to 14%, fourth month to 11%, and fifth month to 3%, sixth month to 2% and seventh month at 1% and from the eighth month, the rate of follow up was 0%. Uptake and retention of PrEP was low among young females as measured against the total tested HIV negative.
Similar content being viewed by others
Change history
13 October 2022
A Correction to this paper has been published: https://doi.org/10.1007/s10461-022-03891-3
References
Chan PA, Patel RR, Mena L, Marshall BD, Rose J, Sutten Coats C, et al. Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States. J Int AIDS Soc. 2019;22(8): e25385.
Sweeney P, Hoyte T, Mulatu MS, Bickham J, Brantley AD, Hicks C, et al. Implementing a data to care strategy to improve health outcomes for people with HIV: a report from the care and prevention in the United States demonstration project. Public Health Rep. 2018;133:60–74.
Wood SM, Lee S, Barg FK, Castillo M, Dowshen N. Young transgender women’s attitudes toward HIV pre-exposure prophylaxis. J Adolesc Health. 2017;60(5):549–55.
CDC. HIV surveillance report, 2017; vol. 29. Published November 2019. Accessed 06/13/2020. http://www.cdc.gov/HIV/library; 2019.
Eakle R, Weatherburn P, Bourne A. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa. J Int AIDS Soc. 2019;22: e25306.
Eakle R, Venter F, Rees H. Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: can it change the game? Retrovirology. 2018;15(1):1–10.
Weinstein M, Yang OO, Cohen AC. Were, we prepared for PrEP? Five years of implementation. AIDS (London, England). 2017;31(16):2303.
Chan SS, Chappel AR, Maddox KEJ, Hoover KW, Huang YLA, Zhu W, et al. Pre-exposure prophylaxis for preventing acquisition of HIV: a cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015–2016. PLoS Med. 2020;17(4):e1003072.
Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.
Thomas R, Skovdal M, Galizzi MM, Schaefer R, Moorhouse L, Nyamukapa C, et al. Improving risk perception and uptake of pre-exposure prophylaxis (prep) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial. Trials. 2019;20(1):1–9.
Karim SSA, Baxter C. HIV incidence rates in adolescent girls and young women in sub-Saharan Africa. Lancet Glob Health. 2019;7(11):e1470–1.
Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc. 2015;18:19408.
UNAIDS. The prevalence and burden of AIDS among women and or at risk for human immunodeficiency virus infection. HIV Prev Clin Infect Dis. 2019;72(8):1301–11.
UNAIDS. Estimated HIV incidence in the United States, 2010–2016. JAIDS J Acquir Immune Defic Syndr. 2016;74(3):10–34.
Rouffiac A-E, Whiteley L, Brown L, Mena L, Craker L, Healy M, et al. A mobile intervention to improve uptake of pre-exposure prophylaxis for southern black men who have sex with men: protocol for intervention development and pilot randomized controlled trial. JMIR Res Protoc. 2020;9(2): e15781.
Ajayi AI, Mudefi E, Yusuf MS, Adeniyi OV, Rala N, Ter Goon D. Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings. Medicine. 2019;98(43):1.
Collier KL, Colarossi LG, Sanders K. Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York City: community and provider perspectives. J Health Commun. 2017;22(3):183–9.
Ya-lin AH, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67(41):1147.
Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice. New York: Lippincott Williams & Wilkins; 2018.
Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The health belief model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun. 2016;30(6):566–76.
Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS ONE. 2020;15(4): e0228620.
Kagaayi J, Batte J, Nakawooya H, Kigozi B, Nakigozi G, Strömdahl S, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda. J Int AIDS Soc. 2020;23(8): e25588.
Wu L, Schumacher C, Chandran A, Fields E, Price A, Greenbaum A, et al. Patterns of PrEP retention among HIV pre-exposure prophylaxis users in Baltimore City, Maryland. J Acquir Immune Defic Syndr. 2020;85(5):593–600.
Acknowledgements
We would like to thank all the clinics that took part in this study and the statistician—Professor S. Olorunju who offered statistical guidance
Funding
This paper was supported by funds from the National Research Foundation of South Africa (orcid.org/0000-0002-5603-2920) and the University of Pretoria Postgraduate Bursary (20814594).
Author information
Authors and Affiliations
Contributions
Author 1, Prepared the original manuscript draft; 1,2,3 and 4 reviewed and edited manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: "The authors' decision to cancel Open Access the copyright of the article changed on 2nd October to © Springer Science+Business Media, LLC, part of Springer Nature 2022 with all rights reserved.
Rights and permissions
About this article
Cite this article
Mudau, D.O., Mulaudzi, F.M., Sepeng, N.V. et al. Assessing HIV Pre-exposure Prophylaxis Uptake and Retention Amongst Young Females in Gauteng Province. AIDS Behav 27, 1182–1187 (2023). https://doi.org/10.1007/s10461-022-03855-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-022-03855-7